Johnson & Johnson Talcum Powder Trial Begins in California
|
Share |
|
Los Angeles, California—California’s first trial alleging that Johnson & Johnson’s talcum powder products (Baby Powder and Shower-to-Shower Powder) have caused ovarian cancer in women who use the products for feminine hygiene will begin today in the Los Angeles Superior Court.
In a pre-trial ruling, the judge presiding over the case dismissed claims against Imery’s Talc, the company that supplies Johnson & Johnson with mined talc. The case will, however, proceed against the pharmaceutical giant.
Eva Echeverria claims that her ovarian cancer was caused by long-term use of Johnson & Johnson’s talcum powder products.
More than 3,000 lawsuits presently are pending against Johnson & Johnson in various state and federal courts throughout the United States. All have raised claims similar to those of Ms. Echverria.
Five trials already have been concluded in Missouri state courts. Plaintiffs were awarded substantial verdicts against Johnson & Johnson in four of them. One trial was decided in favor of the Company.
Talcum Powder Lawsuit News
Largest Jury Verdict to Date in Talcum Powder Ovarian Cancer Trials
On Monday, a Los Angeles jury awarded damages of $417 million to Eva Echeverria in connection with her decades-long use of Johnson & Johnson Baby Powder for feminine hygiene purposes.Johnson & Johnson Talcum Powder Trial Begins in California
California's first trial alleging that Johnson & Johnson's talcum powder products (Baby Powder and Shower-to-Shower Powder) have caused ovarian cancer in whomen who use the products for feminine hygiene will begin today in the Los Angeles Superior Court.J&J Hit with Largest Verdict Yeet in Talcum Powder Trials
On Thursday, a Missouri state court jury ordered Johnson & Johnson to pay a Virginia woman more than $110 million based on her claim that she developed ovarian cancer after decades of using the company's talcum powder products for feminine hygiene.Fifth Talcum Powder Cancer Case Set for Trial in April
Johnson & Johnson will face a fifth trial beginning April 10th alleging that its popular talcum powder products have caused ovarian or uterine cancer in women who used them for feminine hygiene.